(Q28193100)

9

0 references

Paul W. Armstrong

Paul W Armstrong

6

0 references

Robert Califf

8

Robert M Califf

0 references

Erik Magnus Ohman

10

E Magnus Ohman

0 references

David J Moliterno

7

David J Moliterno

0 references

Vic Hasselblad

5

Vic Hasselblad

0 references

L Kristin Newby

2

L Kristin Newby

0 references

Warren J Cantor

1

Warren J Cantor

0 references

author name string

Robert H Christenson

3

0 references

Robert H Tuttle

Journal of the American College of Cardiology

4

0 references

language of work or name

English

0 references

publication date

5 June 2002

0 references

published in

0 references

volume

39

0 references

issue

11

0 references

page(s)

1738-44

0 references

cites work

Myonecrosis after revascularization procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901877-6

7 January 2021

Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901877-6

7 January 2021

Troponisms, necrosettes, enzyme leaks, creatinine phosphokinase bumps, and infarctlets: what's behind this new lexicon and what does it add?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901877-6

7 January 2021

Long-term oral platelet glycoprotein IIb/IIIa receptor antagonism with sibrafiban after acute coronary syndromes: study design of the sibrafiban versus aspirin to yield maximum protection from ischemic heart events post-acute coronary syndromes (SYM

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901877-6

7 January 2021

Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901877-6

7 January 2021

Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901877-6

7 January 2021

Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial Ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901877-6

7 January 2021

Side-branch occlusion during percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901877-6

7 January 2021

Significance of cardiac troponin T release after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901877-6

7 January 2021

Recombinant hirudin (HBW 023) prevents troponin T release after coronary angioplasty in patients with unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901877-6

7 January 2021

Troponin T, troponin I and creatine kinase-MB mass after elective coronary stenting.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901877-6

7 January 2021

Uncomplicated successful percutaneous transluminal coronary angioplasty does not affect cardiac troponin T plasma concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901877-6

7 January 2021

Myocardial damage during percutaneous transluminal coronary angioplasty as evidenced by troponin T measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901877-6

7 January 2021

Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901877-6

7 January 2021

Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901877-6

7 January 2021

Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901877-6

7 January 2021

Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901877-6

7 January 2021

Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901877-6

7 January 2021

Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901877-6

7 January 2021

Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2901877-6

7 January 2021